07/03/2019
2:36 PM | MEI Pharma (Issuer)
Urso David M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
07/03/2019
2:36 PM | Mass Robert D. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:35 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:35 PM | Drazba Brian G. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:34 PM | MEI Pharma (Issuer)
White Christine Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:33 PM | MEI Pharma (Issuer)
Rueckert William Dodge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:33 PM | MEI Pharma (Issuer)
Reynolds Thomas C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:32 PM | Glover Nicholas (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:32 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:31 PM | Clemens Kevan (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:31 PM | Baltic Charles V. III (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:30 PM | HOWSON TAMAR D (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
2:29 PM | HOWSON TAMAR D (Reporting)
MEI Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2019
2:00 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
3:02 PM | MEI Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/14/2019
3:54 PM | CAXTON CORP (Filed by)
MEI Pharma (Subject)
| Form SC 13G/A
| |
02/14/2019
2:37 PM | MEI Pharma (Subject)
Vivo Opportunity, LLC (Filed by)
| Form SC 13G/A
| |
02/14/2019
2:17 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
MEI Pharma (Subject)
| Form SC 13G/A
| |
02/07/2019
3:11 PM | MEI Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/07/2019
3:01 PM | MEI Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/03/2018
4:27 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2018
4:30 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2018
3:23 PM | MEI Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2018
7:00 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2018
3:23 PM | MEI Pharma (Filer)
| Form DEFA14A
| |
10/11/2018
3:18 PM | MEI Pharma (Filer)
| Form DEF 14A
| |
09/06/2018
7:20 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4/A
| |
08/30/2018
3:01 PM | MEI Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
08/08/2018
5:01 PM | MEI Pharma (Issuer)
Urso David M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
5:00 PM | Mass Robert D. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
4:59 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:35 PM | MEI Pharma (Issuer)
Urso David M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:34 PM | Mass Robert D. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:33 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:32 PM | Drazba Brian G. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:30 PM | MEI Pharma (Issuer)
White Christine Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:29 PM | MEI Pharma (Issuer)
Rueckert William Dodge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:28 PM | MEI Pharma (Issuer)
Reynolds Thomas C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:27 PM | Glover Nicholas (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:26 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:25 PM | Clemens Kevan (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
4:24 PM | Baltic Charles V. III (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
3:47 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2018
1:33 PM | Drazba Brian G. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2018
1:27 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2018
1:27 PM | Mass Robert D. (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2018
1:27 PM | MEI Pharma (Issuer)
Urso David M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
11:15 PM | MEI Pharma (Filer)
| Form EFFECT
| |
06/18/2018
3:23 PM | MEI Pharma (Filer)
| Form 424B3
| |
06/06/2018
4:03 PM | MEI Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/04/2018
7:31 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2018
3:41 PM | MEI Pharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/29/2018
4:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
MEI Pharma (Subject)
| Form SC 13G
| |
05/23/2018
3:12 PM | Growth Equity Opportunities V, LLC (Filed by)
MEI Pharma (Subject)
| Form SC 13D
| |
05/16/2018
4:27 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2018
7:01 AM | MEI Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/30/2018
1:14 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2018
1:35 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2018
12:12 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2018
12:11 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2018
7:31 AM | MEI Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/01/2017
3:01 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2017
5:39 PM | Baltic Charles V. III (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
